Sfoglia per AUTORE
PLATZBECKER U
Collezione AOU Città della Salute di Torino

  

Items : 8

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study. in Leukemia / Leukemia. 2024 Oct;38(10):2259-2265. doi: 10.1038/s41375-024-02360-1. Epub 2024 Aug 5.
2024
AOU Città della Salute di Torino

Pomares H; Poloni A; Pietrantuono G; Perez CA; Vara Pampliega M; Molero A; Latagliata R; Hernandez Mohedo F; Kubasch AS; Jimenez MJ; Ganster C; Freja E; Frairia C; Fozza C; Finelli C; Kündgen A; Crugnola M; Ciancia R; Cerrano M; Capodanno I; Calvisi A; López Cadenas F; Bernal T; Bargay JJ; Barraco D; Al Ali NH; Hofmann WK; Haase D; Platzbecker U; et alii...

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA. in HemaSphere / Hemasphere. 2023 Aug 30;7(9):e944. doi: 10.1097/HS9.0000000000000944. eCollection 2023 Sep.
2023
AOU Città della Salute di Torino

Efficace F; Al Essa W; Platzbecker U; Niscola P; Palumbo GA; Caocci G; Cottone F; Breccia M; Luppi M; Stauder R; Ricco A; Petranovic D; Baron F; Voso MT; Fianchi L; Frairia C; Capodanno I; Sarlo C; Fedele M; Lemoli RM; Invernizzi R; Vallisa D; Di Renzo N; Fozza C; Doro M; Giesinger JM; Vignetti M;

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 May 20;41(15):2827-2842. doi: 10.1200/JCO.22.01784. Epub 2023 Mar 17.
2023
AOU Città della Salute di Torino

Diez-Campelo M; Santini V; Kordasti S; Germing U; Santoro A; Savevski V; Passamonti F; Rambaldi A; Bolli N; Bicchieri M; Nibourel O; Riva E; Zampini M; Oliva EN; Riva M; Voso MT; Giaccone L; Lanino L; Chiusolo P; Mannina D; Russo A; Campagna A; Ubezio M; Tentori CA; D'Amico S; Borin L; Rivoli G; Vago L; Di Grazia C; et alii...

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4370-4379. doi: 10.1182/bloodadvances.2021004649.
2021
AOU Città della Salute di Torino

Efficace F; Platzbecker U; Breccia M; Cottone F; Carluccio P; Salutari P; Di Bona E; Borlenghi E; Autore F; Levato L; Finizio O; Mancini V; D'Ardia S; Schlenk RF; Melillo L; Fumagalli M; Fiedler W; Beltrami G; Fracchiolla NS; Bernardi M; Fazi P; Annibali O; Mayer K; Voso MT; Vignetti M;

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Apr 10;39(11):1223-1233. doi: 10.1200/JCO.20.01659. Epub 2021 Feb 4.
2021
AOU Città della Salute di Torino

Palomo L; Sole F; Kordasti S; Kern W; Rambaldi A; Bolli N; Ciceri F; Passamonti F; Remondini D; Giampieri E; Savevski V; Saitta C; Campagna A; Morabito L; Ubezio M; Riva M; Oliva E; Voso MT; Bacigalupo A; Santini V; Bonifazi F; Bruno B; Borin L; Bernardi M; Angelucci E; Termanini A; Maggioni G; Rossi M; Zampini M; et alii...

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. in Leukemia / Leukemia. 2020 Sep;34(9):2451-2459. doi: 10.1038/s41375-020-0746-8. Epub 2020 Feb 21.
2020
AOU Città della Salute di Torino

Capodanno I; Frairia C; Fianchi L; Luppi M; Petranovic D; Caers J; Ricco A; Stauder R; Caocci G; Palumbo GA; Platzbecker U; Breccia M; Niscola P; Patriarca A; Cella D; Oswald LB; Cottone F; Efficace F; Follini E; Sarlo C; Fazi P; Vignetti M;

2020
AOU Città della Salute di Torino

Fabbiano F; Di Renzo N; Cortelezzi A; Maria D'Arco A; Fozza C; Frairia C; Link H; Schmitz N; Rollig C; Hanel M; Brandts CH; Lubbert M; Wattad M; Annibali O; Salih HR; Hertenstein B; Fiedler W; Brossart P; La Nasa G; Melillo L; Rambaldi A; Cairoli R; Borlenghi E; Breccia M; Sborgia M; Di Bona E; Efficace F; Albano F; Divona M; et alii...

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.
2017
AOU Città della Salute di Torino

Lo-Coco F; Schlenk RF; Ehninger G; Mandelli F; Amadori S; Döhner H; Ganser A; Döhner K; Fabbiano F; Cortelezzi A; Di Renzo N; D'Arco AM; Fozza C; Pogliani EM; Frairia C; Link H; Schmitz N; Röllig C; Hänel M; Brandts CH; Lübbert M; Wattad M; Salih HR; Hertenstein B; Brossart P; Fiedler W; La Nasa G; Melillo L; Rambaldi A; et alii...